Clinical Overview of Ureum Levels in Type II Diabetes Mellitus Patients Infected by COVID-19 Pandemic

Authors

  • Deswidya Sukrisna Hutauruk Department of Health Analyst, Faculty of Health, Universitas Efarina, Indonesia
  • Dame Cinta Hutagalung Department of Health Analyst, Faculty of Health, Universitas Efarina, Indonesia

DOI:

https://doi.org/10.56225/ijgoia.v1i3.71

Keywords:

COVID-19, Diabetes Mellitus, Ureum, patients

Abstract

Pneumonia caused by Coronavirus Disease (Covid-19) first appeared in Wuhan. Diabetes mellitus becomes one of the main risk factors for a person infected with the Covid-19 virus because it is susceptible to infection. Chronic complications in the form of diabetic nephropathy caused by diabetes can also increase the severity and mortality in diabetic patients infected with the Covid-19 virus. This study aims to determine the clinical overview of ureum levels in Covid-19-infected diabetes mellitus patients treated at Efarina Pangkalan Kerinci Hospital. This study was conducted from July to September 2021 at the Laboratory of Efarina Pangkalan Kerinci Hospital. This type of research is descriptive analytics. This examination uses a light intensity measurement method using an autoanalizer with a sample of 30 samples taken at random. The results of the examination of ureum levels in Diabetic Mellitus patients infected with the Covid-19 pandemic at Efarina Pangkalan Kerinci Hospital obtained results that increased by 13 samples (43%) and normal ureum levels by as many as 17 samples (57%). For this reason, patients are advised to conduct regular health checks, eat healthy foods and comply with the 5M health protocol to prevent the transmission of the Covid-19 virus.

References

Abdi, A., Jalilian, M., Sarbarzeh, P. A., & Vlaisavljevic, Z. (2020). Diabetes and COVID-19: A systematic review on the current evidences. Diabetes Research and Clinical Practice, 166, 108347.

Alkundi, A., Mahmoud, I., Musa, A., Naveed, S., & Alshawwaf, M. (2020). Clinical characteristics and outcomes of COVID-19 hospitalised patients with diabetes in the United Kingdom: a retrospective single centre study. Diabetes Research and Clinical Practice, 165, 108263.

Dualib, P. M., Taddei, C. R., Fernandes, G., Carvalho, C. R. S., Sparvoli, L. G., Silva, I. T., Mattar, R., Ferreira, S. R. G., Dib, S. A., & Almeida-Pititto, B. de. (2022). Gut microbiota across normal gestation and gestational diabetes mellitus: A cohort analysis. Metabolites, 12(9), 796.

Ejaz, H., Alsrhani, A., Zafar, A., Javed, H., Junaid, K., Abdalla, A. E., Abosalif, K. O. A., Ahmed, Z., & Younas, S. (2020). COVID-19 and comorbidities: Deleterious impact on infected patients. Journal of Infection and Public Health, 13(12), 1833–1839.

Holman, N., Knighton, P., Kar, P., O’Keefe, J., Curley, M., Weaver, A., Barron, E., Bakhai, C., Khunti, K., & Wareham, N. J. (2020). Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. The Lancet Diabetes & Endocrinology, 8(10), 823–833.

Kingham, E., & Welham, M. (2009). Distinct roles for isoforms of the catalytic subunit of class-IA PI3K in the regulation of behaviour of murine embryonic stem cells. Journal of Cell Science, 122(13), 2311–2321.

Molitoris, B. A., Levin, A., Warnock, D. G., Joannidis, M., Mehta, R. L., Kellum, J. A., Ronco, C., & Shah, S. (2007). Improving outcomes from acute kidney injury. In Journal of the American Society of Nephrology (Vol. 18, Issue 7, pp. 1992–1994). Am Soc Nephrol.

Mustata, G. T., Rosca, M., Biemel, K. M., Reihl, O., Smith, M. A., Viswanathan, A., Strauch, C., Du, Y., Tang, J., & Kern, T. S. (2005). Paradoxical effects of green tea (Camellia sinensis) and antioxidant vitamins in diabetic rats: improved retinopathy and renal mitochondrial defects but deterioration of collagen matrix glycoxidation and cross-linking. Diabetes, 54(2), 517–526.

Rasmussen, S. A., & Thompson, L. A. (2020). Coronavirus disease 2019 and children: what pediatric health care clinicians need to know. JAMA Pediatrics, 174(8), 743–744.

Singh, A. K., Gupta, R., & Misra, A. (2020). Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(4), 283–287.

Smeltzer, S. C. (2014). Smeltzer, SC (2014). Keperawatan medikal bedah (handbook for Brunner & Suddarth’s textbook of medicalsurgical nursing) edisi 12. Diterjemahkan oleh Devi Yulianti & Amelia Kimin. Jakarta: EGC. Jakarta: EGC Medical Book.

World Health Organization. (2021). WHO Coronavirus (COVID-19) Dashboard.

Wu, Z., & McGoogan, J. M. (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. Jama, 323(13), 1239–1242.

Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020). Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis, 94(1), 91–95.

Yasuda, K., Miyagi, H., Hamada, Y., & Takata, Y. (1984). Determination of urea in whole blood using a urea electrode with an immobilised urease membrane. Analyst, 109(1), 61–64.

Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., & Huang, C.-L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270–273.

Downloads

Published

2022-09-30

How to Cite

Hutauruk, D. S., & Hutagalung, D. C. (2022). Clinical Overview of Ureum Levels in Type II Diabetes Mellitus Patients Infected by COVID-19 Pandemic. International Journal of Global Optimization and Its Application, 1(3), 196–201. https://doi.org/10.56225/ijgoia.v1i3.71